Editor(s):
(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems, Propharmex Company, India.
Reviewers:
(1) Jontari Hutagalung, NIHRD-MOH, Indonesia.
(2) Nadia Maria Sposi, Center for Gender-Specific Medicine Istituto Superiore di Sanità, Italy.
(3) Akwuebu Susanna Osiro, Rivers State University, Nigeria.
Additional Reviewers:
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Jontari Hutagalung, Indonesia) | File 1 | File 2
Stage 2 | Peer review report_2 (Nadia Maria Sposi, Italy) | File 1 | NA
Stage 2 | Peer review report_3 (Akwuebu Susanna Osiro, Nigeria) | File 1 | File 2
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA